An internal benefits guide seen by Business Insider shows Deloitte will stop covering GLP-1 drugs for weight loss in its US medical plans and raise deductibles and out-of-pocket maximums on most plans, citing rising healthcare costs.
Your HR stack, with superpowers.
Pick the tools you need. Launch in a day.